Catherine Zimel

Stop the Scanning: CT Scans and Radiation Risk in Pediatric Trauma Patients.

M. Browne, C. Crowder, Catherine Zimel, 2017 .

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

B. Taylor, S. Loi, S. Chandarlapaty, 2019, Cancer discovery.

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

A. Iasonos, H. Won, P. Sabbatini, 2019, Cancer.

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

C. Bourque, B. Taylor, M. Ladanyi, 2022, Nature Communications.

Non-invasive detection of acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations.

M. Berger, G. Iyer, B. Houck-Loomis, 2019, Journal of Clinical Oncology.